Litigation
Celgene Corporation v. Synthon Pharmaceuticals, Inc. et al.
dismissed/consolidated2:19-cv-09737
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2019-04-12
- Terminated
- 2019-05-13
Patents at issue (3)
Plaintiffs (1)
Defendants (2)
Summary
Celgene filed this D.N.J. action against Synthon (Alvogen) on the '262, '939, '428, '427 and the '647/'648/'649 patents. The docket shows termination on May 13, 2019, indicating dismissal or consolidation.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).